D.E. Shaw & Co
BNTX icon

D.E. Shaw & Co’s BioNTech BNTX Stock Holding History

D.E. Shaw & Co’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.8M Sell
199,768
-288,784
-59% -$29.7M 0.01% 1234
2025
Q4 		$46.5M Buy
+488,552
New +$49.2M 0.03% 753
2025
Q2 		– Sell
-16,948
Closed -$1.71M – 4356
2025
Q1 		$1.54M Buy
16,948
+6,998
+70% +$783K ﹤0.01% 2799
2024
Q4 		$1.13M Sell
9,950
-28,395
-74% -$3.24M ﹤0.01% 3131
2024
Q3 		$4.55M Sell
38,345
-30,202
-44% -$2.78M ﹤0.01% 2027
2024
Q2 		$5.51M Buy
68,547
+38,881
+131% +$3.55M 0.01% 1767
2024
Q1 		$2.74M Sell
29,666
-31,615
-52% -$3.03M ﹤0.01% 2384
2023
Q4 		$6.47M Buy
61,281
+19,705
+47% +$1.99M 0.01% 1700
2023
Q3 		$4.52M Buy
41,576
+3,376
+9% +$373K ﹤0.01% 1897
2023
Q2 		$4.12M Buy
38,200
+32,113
+528% +$3.61M ﹤0.01% 2016
2023
Q1 		$758K Sell
6,087
-63,096
-91% -$8.66M ﹤0.01% 3340
2022
Q4 		$10.4M Sell
69,183
-41,132
-37% -$6.33M 0.01% 1391
2022
Q3 		$14.9M Sell
110,315
-234,278
-68% -$35.8M 0.02% 1047
2022
Q2 		$51.4M Sell
344,593
-259,085
-43% -$39.6M 0.06% 383
2022
Q1 		$103M Buy
603,678
+320,584
+113% +$53.9M 0.1% 224
2021
Q4 		$73M Buy
283,094
+8,655
+3% +$2.37M 0.06% 385
2021
Q3 		$74.9M Buy
274,439
+265,493
+2,968% +$84.4M 0.07% 353
2021
Q2 		$2M Sell
8,946
-513
-5% -$96.7K ﹤0.01% 2942
2021
Q1 		$1.03M Sell
9,459
-46,439
-83% -$4.93M ﹤0.01% 3082
2020
Q4 		$4.56M Buy
+55,898
New +$5.49M ﹤0.01% 1948

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

D.E. Shaw & Co's BNTX Position: Q1 2026 in Review

D.E. Shaw & Co reduced its BioNTech (BNTX) stake by 59% in Q1 2026, selling an estimated $29.7M and leaving 199,768 shares worth $17.8M. The position accounts for 0.01% of the portfolio, ranked #1234.

D.E. Shaw & Co first reported a position in BNTX in Q4 2020 and has held it in 20 quarters since. The position peaked at $103M in Q1 2022. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • D.E. Shaw & Co held 199,768 shares of BioNTech worth $17.8M as of Q1 2026.
  • D.E. Shaw & Co sold 288,784 BioNTech shares in Q1 2026, an estimated $29.7M.
  • BioNTech made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1234 holding.
  • D.E. Shaw & Co first reported a position in BioNTech in Q4 2020 and has held it in 20 quarters since.
  • D.E. Shaw & Co's BioNTech position peaked at $103M in Q1 2022.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.